Secondary analysis of a trial in 5919 patients with minor stroke or TIA carrying CYP2C19 loss-of-function alleles: Lp-PLA2 activity did not significantly modify the effect of ticagrelor-aspirin vs clopidogrel-aspirin on 90-day stroke recurrence (interaction P=0.45).
Secondary analysisn = 5,919
Lin et al. Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack